News Releases
-
Jan 12, 2021Evofem honored amongst best companies globally for outstanding innovation with first-in-class non-hormonal prescription contraceptive vaginal gel, Phexxi®
-
Dec 22, 2020Approximately 25 Million Adult Women Covered by Medicaid
-
Dec 17, 2020High Level of Interest from Clinical Sites Seeking to Participate in EVOGUARD Trial
-
Nov 9, 2020Launched Phexxi™ (lactic acid, citric acid, potassium bitartrate) in U.S. for Hormone-free Contraception
-
Oct 27, 2020-- Conference Call Scheduled for 5:00 p.m. ET --